A biomarker-guided approach to cardioprotection in cancer patients receiving anthracyclines is associated with improvements in left ventricular ejection fraction
1. An N-terminal pro–B-type natriuretic peptide (NT-proBNP)-guided approach to neurohormonal therapy for cardioprotection in patients receiving anthracyclines for breast cancer ...
